Literature DB >> 15120617

TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.

Hongri Xu1, Atsushi Okamoto, Jiro Ichikawa, Takashi Ando, Kachio Tasaka, Keisuke Masuyama, Hideoki Ogawa, Hideo Yagita, Ko Okumura, Atsuhito Nakao.   

Abstract

TNF-like weak inducer of apoptosis (TWEAK), a member of the tumor necrosis factor (TNF) family, is a multifunctional cytokine that regulates cellular proliferation, angiogenesis, inflammation, and apoptosis. In this study, we investigated the effect of TWEAK on human bronchial epithelial cells. A human bronchial epithelial cell line, BEAS2B, expressed a TWEAK receptor, fibroblast growth factor-inducible 14 (Fn14), and produced IL-8 and GM-CSF upon TWEAK stimulation in a dose-dependent manner, which was abrogated by anti-Fn14 blocking antibody. TWEAK induced phosphorylation of IkappaBalpha and BAY11-7082, a selective inhibitor of IkappaBalpha phosphorylation, inhibited the TWEAK-induced IL-8 and GM-CSF production by BEAS2B cells. Moreover, primary cultured human bronchial epithelial cells also expressed Fn14 and produced IL-8 and GM-CSF upon TWEAK stimulation. Collectively, TWEAK stimulated human bronchial epithelial cells to produce IL-8 and GM-CSF through Fn14. Because IL-8 and GM-CSF are associated with inflammatory conditions, these results suggest that TWEAK/Fn14 interaction may play some roles in airway inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120617     DOI: 10.1016/j.bbrc.2004.04.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

2.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.

Authors:  Marjaneh Razmara; Brendan Hilliard; Azadeh K Ziarani; Ramachandran Murali; Srikanth Yellayi; Mustafa Ghazanfar; Youhai H Chen; Mark L Tykocinski
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

4.  A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.

Authors:  Manuel Yepes; Sharron A N Brown; Elizabeth G Moore; Elizabeth P Smith; Daniel A Lawrence; Jeffrey A Winkles
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Highly conserved transcriptional responses to mechanical ventilation of the lung.

Authors:  Kenneth S Kompass; Gaetan Deslee; Carla Moore; Donald McCurnin; Richard A Pierce
Journal:  Physiol Genomics       Date:  2010-05-11       Impact factor: 3.107

6.  Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.

Authors:  Eugene S Han; Samrawit Mekasha; Robin R Ingalls
Journal:  J Reprod Immunol       Date:  2009-12-05       Impact factor: 4.054

7.  The cytokine TWEAK modulates renal tubulointerstitial inflammation.

Authors:  Ana Belen Sanz; Pilar Justo; Maria Dolores Sanchez-Niño; Luis Miguel Blanco-Colio; Jeffrey A Winkles; Matthias Kreztler; Aniela Jakubowski; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 8.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 9.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

10.  The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.

Authors:  Woldeab B Haile; Ramiro Echeverry; Jialing Wu; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.